The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zomedica Corp (AMEX: ZOM) closed the day trading at $0.15 down -5.54% from the previous closing price of $0.16. In other words, the price has decreased by -$5.54 from its previous closing price. On the day, 6.72 million shares were traded. ZOM stock price reached its highest trading level at $0.151 during the session, while it also had its lowest trading level at $0.144.
Ratios:
For a better understanding of ZOM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.68 and its Current Ratio is at 11.39. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Dawson James on January 06, 2023, initiated with a Buy rating and assigned the stock a target price of $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 12 ’24 when Klass Russell Kevin bought 299,993 shares for $0.16 per share. The transaction valued at 46,529 led to the insider holds 2,000,050 shares of the business.
Klass Russell Kevin bought 500,000 shares of ZOM for $75,100 on Jun 11 ’24. The Vice President of Sales now owns 1,700,057 shares after completing the transaction at $0.15 per share. On Jun 10 ’24, another insider, Klass Russell Kevin, who serves as the Vice President of Sales of the company, bought 200,007 shares for $0.15 each. As a result, the insider paid 29,941 and bolstered with 1,200,057 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZOM now has a Market Capitalization of 146399264 and an Enterprise Value of 71728184. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.51 while its Price-to-Book (P/B) ratio in mrq is 0.69. Its current Enterprise Value per Revenue stands at 2.762 whereas that against EBITDA is -2.599.
Stock Price History:
The Beta on a monthly basis for ZOM is 1.04, which has changed by -0.16216218 over the last 52 weeks, in comparison to a change of 0.24841464 over the same period for the S&P500. Over the past 52 weeks, ZOM has reached a high of $0.23, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is -1.70%, while the 200-Day Moving Average is calculated to be -4.26%.
Shares Statistics:
Over the past 3-months, ZOM traded about 4.09M shares per day on average, while over the past 10 days, ZOM traded about 3177790 shares per day. A total of 979.95M shares are outstanding, with a floating share count of 962.81M. Insiders hold about 1.75% of the company’s shares, while institutions hold 8.31% stake in the company. Shares short for ZOM as of 1722384000 were 56658402 with a Short Ratio of 13.86, compared to 1719532800 on 61524931. Therefore, it implies a Short% of Shares Outstanding of 56658402 and a Short% of Float of 5.7700000000000005.
